SUMMARY: This study showed that regional bone blood flow and (18)F-fluoride bone plasma clearance measured by positron emission tomography are three times lower at the hip than the lumbar spine. INTRODUCTION: Measurements of effective bone plasma flow (K (1)), bone plasma clearance (K ( i )) and standardised uptake values (SUV) using (18)F-fluoride positron emission tomography ((18)F-PET) provide a useful means of studying regional bone metabolism at different sites in the skeleton. This study compares the regional (18)F-fluoride kinetics and SUV at the hip and lumbar spine (LS). METHODS: Twelve healthy postmenopausal women with no history of metabolic bone disease apart from two with untreated osteoporosis were recruited. Each subject underwent 60-min dynamic (18)F-PET scans at the LS and proximal femur two weeks apart. K (1), K ( i ) and SUV were measured at the LS (mean of L(1)-L(4)), femoral neck (FN), total hip (TH) and femoral shaft (FS). Differences between sites were assessed using the nonparametric Kruskal-Wallis test with a Bonferroni correction for multiple comparisons. RESULTS: Values of K (1), K ( i ) and SUV at the FN, TH and FS were three times lower than at the LS (p = 0.003). Amongst the proximal femur sites, K ( i ) and SUV were lower at the FS compared with the FN and TH, and SUV was lower at the TH compared with the FN (all p < 0.05). The volume of distribution was lower at the TH and FS compared with the LS (p < 0.05). CONCLUSION: The lower values of K (1), K ( i ) and SUV at the hip suggest that lower bone blood flow in the proximal femur is an important factor explaining the principal reason for the differences in bone fluoride kinetics between the LS and hip sites.
SUMMARY: This study showed that regional bone blood flow and (18)F-fluoride bone plasma clearance measured by positron emission tomography are three times lower at the hip than the lumbar spine. INTRODUCTION: Measurements of effective bone plasma flow (K (1)), bone plasma clearance (K ( i )) and standardised uptake values (SUV) using (18)F-fluoride positron emission tomography ((18)F-PET) provide a useful means of studying regional bone metabolism at different sites in the skeleton. This study compares the regional (18)F-fluoride kinetics and SUV at the hip and lumbar spine (LS). METHODS: Twelve healthy postmenopausal women with no history of metabolic bone disease apart from two with untreated osteoporosis were recruited. Each subject underwent 60-min dynamic (18)F-PET scans at the LS and proximal femur two weeks apart. K (1), K ( i ) and SUV were measured at the LS (mean of L(1)-L(4)), femoral neck (FN), total hip (TH) and femoral shaft (FS). Differences between sites were assessed using the nonparametric Kruskal-Wallis test with a Bonferroni correction for multiple comparisons. RESULTS: Values of K (1), K ( i ) and SUV at the FN, TH and FS were three times lower than at the LS (p = 0.003). Amongst the proximal femur sites, K ( i ) and SUV were lower at the FS compared with the FN and TH, and SUV was lower at the TH compared with the FN (all p < 0.05). The volume of distribution was lower at the TH and FS compared with the LS (p < 0.05). CONCLUSION: The lower values of K (1), K ( i ) and SUV at the hip suggest that lower bone blood flow in the proximal femur is an important factor explaining the principal reason for the differences in bone fluoride kinetics between the LS and hip sites.
Authors: Tanuj Puri; Glen M Blake; Michelle L Frost; Amelia E B Moore; Musib Siddique; Gary J R Cook; Paul K Marsden; Ignac Fogelman; Kathleen M Curran Journal: Nucl Med Commun Date: 2011-09 Impact factor: 1.690
Authors: Tanuj Puri; Glen M Blake; Musib Siddique; Michelle L Frost; Gary J R Cook; Paul K Marsden; Ignac Fogelman; Kathleen M Curran Journal: Nucl Med Commun Date: 2011-06 Impact factor: 1.690
Authors: C Messa; W G Goodman; C K Hoh; Y Choi; A R Nissenson; I B Salusky; M E Phelps; R A Hawkins Journal: J Clin Endocrinol Metab Date: 1993-10 Impact factor: 5.958
Authors: Rhonda D Prisby; Michael W Ramsey; Brad J Behnke; James M Dominguez; Anthony J Donato; Matthew R Allen; Michael D Delp Journal: J Bone Miner Res Date: 2007-08 Impact factor: 6.741
Authors: James F Griffith; David K W Yeung; Polly H Tsang; Kai C Choi; Timothy C Y Kwok; Anil T Ahuja; Kwok S Leung; Ping C Leung Journal: J Bone Miner Res Date: 2008-07 Impact factor: 6.741
Authors: T Derlin; T Janssen; J Salamon; S Veldhoen; J D Busch; G Schön; J Herrmann; F O Henes; P Bannas; G Adam Journal: Osteoporos Int Date: 2014-08-16 Impact factor: 4.507
Authors: Viral N Shah; R Dana Carpenter; Virginia L Ferguson; Ann V Schwartz Journal: Curr Opin Endocrinol Diabetes Obes Date: 2018-08 Impact factor: 3.243
Authors: J C Regelink; P G Raijmakers; N Bravenboer; R Milek; N J Hoetjes; A M de Kreuk; M van Duin; M J Wondergem; P Lips; P Sonneveld; J M Zijlstra; S Zweegman Journal: EJNMMI Res Date: 2016-05-31 Impact factor: 3.138
Authors: Marloes J M Peters; Roel Wierts; Elisabeth M C Jutten; Servé G E A Halders; Paul C P H Willems; Boudewijn Brans Journal: Ann Nucl Med Date: 2015-08-05 Impact factor: 2.668